Celularity Inc (CELU) stock
CELUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.57−0.05 (-7.75%)
Close on Nov 17, 2026Market cap $18.53MP/E –Yield –
Celularity pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Celularity's pe ratio was 5.1× on Jul 31, 2023.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Jul 31, 2023 | 5.1× | −5.6 |
| 2022 | Oct 31, 2022 | 10.8× | −5.3 |
| 2020 | Apr 30, 2020 | 16.0× | – |
See a number that looks wrong?